• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VGE

Unknown

0.71% ! $55.61
Currently unlisted.
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
VGE
Ann: Outstanding ETF Securities and Fund Flows Announcement 		04/09/25 0 44
04/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  44 
VGE
Ann: ETF Annual Statements 		08/08/25 0 120
08/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  120 
VGE
Ann: Outstanding ETF Securities and Fund Flows Announcement 		06/08/25 0 103
06/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  103 
VGE
Ann: Exit Statement 		29/07/25 0 111
29/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  111 
VGE
Ann: FATCA and CRS Tax Residency Certification Reminder 		24/07/25 0 113
24/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  113 
VGE
Ann: Outstanding ETF Securities and Fund Flows Announcement 		07/07/25 0 147
07/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  147 
VGE
Ann: Distribution Tax Estimates 		02/07/25 0 164
02/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  164 
VGE
Ann: DRP Issue Price Announcement 		02/07/25 0 153
02/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  153 

See All Discussions arrow Created with Sketch.

Timeline

Outstanding ETF Securities and Fund Flows Announcement
04 Sep 16:47
 
ETF Annual Statements
08 Aug 15:23
 
Outstanding ETF Securities and Fund Flows Announcement
06 Aug 15:06
 
Exit Statement
29 Jul 11:57
 
FATCA and CRS Tax Residency Certification Reminder
24 Jul 09:44
 
Outstanding ETF Securities and Fund Flows Announcement
07 Jul 10:39
 
View More arrow Created with Sketch.

Featured News

NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Peninsula shares jump as company flags first yellowcake production. Is this a new leaf?

Peninsula Energy has seen a green day based on positively-received newsflow for the first time in what feels like a long time.
Future Battery Minerals identifies strong regolith gold anomalism at Canyon Future Battery MD and CEO, Nick Rathjen, joins HotCopper to unpack the company's glittering assay results at its Miriam project.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
Amaero's big move: Exclusive deal, big targets, and a lot on the line Amaero has just pulled off a deal that establishes its first-mover advantage: An exclusive five-year supply agreement with Titomic.
Orthocell jumps as nerve repair tech shows hope for erectile dysfunction post-prostate surgery Orthocell shares popped +10% as the company reported its flagship nerve repair product, Remplir, is being used by Australian urologists.

Featured News

NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.